Finding a non-invasive way to predict effectiveness of cancer therapy

by Society of Nuclear Medicine and Molecular ImagingBiodistribution of 89Zr-labeled mAb: physiologic components. (A) Reversible nonspecific uptake due to antibody in vascular tissue compartment and an

Updated on: December 22,2023

Finding a non-invasive way to predict effectiveness of cancer therapy

by Society of Nuclear Medicine and Molecular ImagingBiodistribution of 89Zr-labeled mAb: physiologic components. (A) Reversible nonspecific uptake due to antibody in vascular tissue compartment and an

Updated on:December 22,2023

Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation

by Krista Conger,Stanford UniversityScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDCAR-T cell therapy, which

Updated on: July 17,2024

Trial of cell-based therapy for high-risk lymphoma leads to FDA breakthrough designation

by Krista Conger,Stanford UniversityScanning electron micrograph of a human T lymphocyte (also called a T cell) from the immune system of a healthy donor. Credit: NIAIDCAR-T cell therapy, which

Updated on:July 17,2024

Tiny, implantable therapeutic sponge device helps kill cancer in mice

by Wayne Lewis,University of California, Los AngelesThe SymphNode device (left), contains nanoparticles (red dots) that release a drug that blocks the activity of regulatory T cells (green), whi

Updated on: January 08,2024

Tiny, implantable therapeutic sponge device helps kill cancer in mice

by Wayne Lewis,University of California, Los AngelesThe SymphNode device (left), contains nanoparticles (red dots) that release a drug that blocks the activity of regulatory T cells (green), whi

Updated on:January 08,2024

Researchers find genetic variant contributing to disparities in childhood leukemia risk

by Keck School of Medicine of USCCredit: CC0 Public DomainAcute lymphoblastic leukemia (ALL), the most common childhood cancer, disproportionately affects children of Hispanic/Latino origin in th

Updated on: March 27,2024

Researchers find genetic variant contributing to disparities in childhood leukemia risk

by Keck School of Medicine of USCCredit: CC0 Public DomainAcute lymphoblastic leukemia (ALL), the most common childhood cancer, disproportionately affects children of Hispanic/Latino origin in th

Updated on:March 27,2024

Cancer biology: Some cancer cells can lose their capability to migrate

Updated on: December 18,2023

Cancer biology: Some cancer cells can lose their capability to migrate

Updated on:December 18,2023

A blood test that screens for multiple cancers at once promises to boost early detection

by Colin Pritchard,The ConversationDNA contains molecular patterns that indicate where in the body it came from. Credit:CNX OpenStax/Wikimedia Commons,CC BYDetecting cancer early bef

Updated on: February 20,2024

A blood test that screens for multiple cancers at once promises to boost early detection

by Colin Pritchard,The ConversationDNA contains molecular patterns that indicate where in the body it came from. Credit:CNX OpenStax/Wikimedia Commons,CC BYDetecting cancer early bef

Updated on:February 20,2024

First map of circular DNA in childhood cancer

byCharité - Universitätsmedizin BerlinDNA of a neuroblastoma cell: Between the chromosomes (blue) there are numerous small DNA rings (green). The centromere of chromosome 2 is stained red. Credi

Updated on: December 22,2023

First map of circular DNA in childhood cancer

byCharité - Universitätsmedizin BerlinDNA of a neuroblastoma cell: Between the chromosomes (blue) there are numerous small DNA rings (green). The centromere of chromosome 2 is stained red. Credi

Updated on:December 22,2023

'Masked' cancer drug stealthily trains immune system to kill tumors while sparing healthy tissues

by Aslan Mansurov,The ConversationDendritic cells (green) produce cytokines like IL-12, which can train T cells (pink) to attack tumors. Credit:Victor Segura Ibarra and Rita Serda/National

Updated on: March 30,2024

'Masked' cancer drug stealthily trains immune system to kill tumors while sparing healthy tissues

by Aslan Mansurov,The ConversationDendritic cells (green) produce cytokines like IL-12, which can train T cells (pink) to attack tumors. Credit:Victor Segura Ibarra and Rita Serda/National

Updated on:March 30,2024

Epigenetic therapy worth pursuing in hormone receptor positive advanced breast cancer

byEuropean Society for Medical OncologyCredit: CC0 Public DomainEpigenetic therapy with histone deacetylase (HDAC) inhibitors is worth pursuing in hormone receptor positive advanced breast cance

Updated on: December 18,2023

Epigenetic therapy worth pursuing in hormone receptor positive advanced breast cancer

byEuropean Society for Medical OncologyCredit: CC0 Public DomainEpigenetic therapy with histone deacetylase (HDAC) inhibitors is worth pursuing in hormone receptor positive advanced breast cance

Updated on:December 18,2023

New insights into how blood pressure drug may benefit patients with locally advanced pancreatic cancer

byMassachusetts General HospitalCredit: Unsplash/CC0 Public DomainPancreatic cancer is highly lethal, and surgical removal of tumor tissue is currently the only potential cure for most patients.

Updated on: December 26,2023

New insights into how blood pressure drug may benefit patients with locally advanced pancreatic cancer

byMassachusetts General HospitalCredit: Unsplash/CC0 Public DomainPancreatic cancer is highly lethal, and surgical removal of tumor tissue is currently the only potential cure for most patients.

Updated on:December 26,2023

Research highlights breast cancer risk for female firefighters

bySilent Spring InstituteCredit: Pixabay/CC0 Public DomainIt's well documented that firefighters have significantly higher rates of cancer than the general population, and these elevated rat

Updated on: December 02,2024

Research highlights breast cancer risk for female firefighters

bySilent Spring InstituteCredit: Pixabay/CC0 Public DomainIt's well documented that firefighters have significantly higher rates of cancer than the general population, and these elevated rat

Updated on:December 02,2024

Patients with high-risk melanoma had better quality of life on pembrolizumab than on standard immunotherapy regimens

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainPatients with high-risk stage III-IV melanoma who received pembrolizumab after their surgery reported a better quality of life than pati

Updated on: December 22,2023

Patients with high-risk melanoma had better quality of life on pembrolizumab than on standard immunotherapy regimens

by SWOG Cancer Research NetworkCredit: Pixabay/CC0 Public DomainPatients with high-risk stage III-IV melanoma who received pembrolizumab after their surgery reported a better quality of life than pati

Updated on:December 22,2023